Panitumumab and Irinotecan for Malignant Gliomas
Clinical trial NCT01017653 · TERMINATED
Trial details
- NCT number
- NCT01017653
- Sponsor
- Annick Desjardins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-10-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.